Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Oramed Announces $6.5 Million Milestone Payment from HTIT

JERUSALEM, June 21, 2016 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (, a developer of oral drug delivery systems, today announced that Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT) is transferring a $6.5 million milestone payment from the previously-announced license and investment agreement between Oramed and HTIT.  The payment follows Oramed’s positive top-line results […]

Read More »

Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer

NEWARK, N.J., June  21, 2016 /PRNewswire/ — Neurotrope, Inc. (OTCQB: NTRP): today announced that Paula T. Trzepacz, M.D., has joined Neurotrope BioScience, Inc., the Company’s wholly owned operating subsidiary, as its Executive Vice President and Chief Medical Officer. Prior to joining Neurotrope, Dr. Trzepacz was at Eli Lilly and Company for over 15 years where she […]

Read More »

Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement

AUSTIN, Texas, June 21, 2016 /PRNewswire/ — Lumos Pharma, Inc. has further expanded its management team with the appointment of Carol A. Dutch as Senior Director, Patient Engagement. Ms. Dutch will create and lead global patient engagement projects to support the clinical development and pre-commercial phases of Lumos’ rare and orphan disease pipeline projects. Over […]

Read More »

Many patients at risk for stroke get wrong medicine

Reuters Health – More than a third of patients with a heart rhythm problem that can cause a stroke are incorrectly given aspirin instead of the blood-thinning medications they need to make this complication less likely, a U.S. study suggests. Most strokes occur when an artery that carries blood to the brain gets blocked by […]

Read More »

Trek Therapeutics Initiates Phase 2a Study of Faldaprevir and TD-6450, With and Without Ribavirin, in Patients with HCV GT 1b.

CAMBRIDGE, Mass., June 21, 2016 /PRNewswire/ — Trek Therapeutics (TREKtx), a private, clinical stage public benefit corporation developing affordable and accessible treatment regimens for chronic hepatitis C virus (HCV) infections has initiated a Phase 2a study evaluating TD-6450 plus faldaprevir (FDV) with and without ribavirin (RBV) in patients with genotype 1b (GT 1b) HCV infection […]

Read More »

Zika’s impact on children will require new medical approach: expert

The spread of Zika virus through the Americas is likely to affect tens of thousands of children with a wide range of neurological and psychiatric problems in the next year, requiring a new approach to their care, a leading U.S. disease expert said on Monday. Dr. Peter Hotez, of the National School of Tropical Medicine […]

Read More »

Attorney General Rejects VEB’s Request Regarding Mylan Shareholder Approval of Meda Transaction

HERTFORDSHIRE, England, and PITTSBURGH, June 20, 2016 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today confirmed that the Attorney General of the Netherlands has rejected the request of the Dutch group VEB to initiate enquiry proceedings at the Enterprise Chamber of the Amsterdam Court of Appeal in respect of VEB’s opinion that Mylan’s shareholders should approve […]

Read More »

Epizyme to Continue Blood Cancer Trials as Tumors Were Wiped Out in Some Patients

  Tazemetostat demonstrates favorable safety profile consistent with prior clinical experience   Four of five cohorts have now surpassed futility, including follicular lymphoma with EZH2 mutation; responses observed in all patient cohorts   CAMBRIDGE, Mass.–(BUSINESS WIRE)– Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today reported preliminary data from its ongoing, […]

Read More »

Cat allergy flop torpedoes high-profile UK biotech Circassia

<span class="articleLocation”>Circassia Pharmaceuticals lost nearly two-thirds of its value on Monday as its experimental cat allergy treatment failed in a late-stage trial, dealing a major blow to the high-profile British biotech company. Circassia listed on the London stock market in March 2014 in Britain’s largest biotech flotation for decades and last year it expanded by […]

Read More »

SoCal’s Regulus Locks in $30 Million

  LA JOLLA, Calif., June 20, 2016 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced it has entered into a $30 million loan and security agreement with Oxford Finance LLC. Proceeds from the loan will be used to provide additional working […]

Read More »

Bayer AG Mulls Sale of $3 Billion Radiology Business

Bayer AG is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.

Read More »

Novartis AG Pledges to Nearly Triple Biosimilar Drugs on Market By 2020

Switzerland’s Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines will snatch billions in rivals’ profits. Novartis’s Sandoz generics unit aims to be selling eight biosimilars, compared with three now, as patents on original drugs expire. […]

Read More »

Publicis Health Wins 11 Cannes Lions at Lions Health Festival

CANNES, France, June 20, 2016 /PRNewswire/ — Publicis Health, the largest health-oriented agency group in the world, was recognized with 11 Cannes Lions at the 2016 Lions Health Festival this weekend. The group was honored with three silver and six bronze awards across two agencies for work that inspired life-changing behavior. Publicis Health came in […]

Read More »

Congo declares yellow fever epidemic, 1,000 suspected cases

Democratic Republic of Congo declared a yellow fever epidemic in three provinces including the capital Kinshasa on Monday after confirming 67 cases of the disease, with another 1,000 suspected cases being monitored. Health Minister Felix Kabange said seven of the proven cases were autochthonous, while 58 were imported from Angola, where the outbreak began. A […]

Read More »

MTPC Submits NDA for Edaravone to Treat ALS

Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States   OSAKA, Japan, June 20, 2016 /PRNewswire/ — Mitsubishi Tanabe Pharma Corporation (MTPC) (Head Office: Osaka; President & Representative Director, CEO: Masayuki Mitsuka), today announced that a New Drug Application has been submitted to the U.S. Food and Drug […]

Read More »

Never-Before Human-Detected, Potentially Pathogenic Bacterium Found in Children With Acute Leukemia

BOSTON, June 20, 2016 /PRNewswire/ — Researchers at the Human Microbiology Institute (HMI) have discovered a novel bacteria in the saliva of children with acute leukemia that they say could be linked to deadly, drug-resistant pneumonia in patients with blood cancer. Photo – In an abstract presented over the weekend at ASM Microbe 2016, the […]

Read More »

VistaGen Therapeutics Appoints Pharmaceutical CNS Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., June 20, 2016 /PRNewswire/ — VistaGen Therapeutics, Inc. (NASDAQ: VTGN) (VistaGen or the Company), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the central nervous system (CNS), today announced it has appointed Mark A. Smith, M.D., Ph.D., as Chief Medical Officer. […]

Read More »

Inovio Pharma gets green signal to test Zika vaccine in human trial

Drug developer Inovio Pharmaceuticals Inc and its partner GeneOne Life Sciences Inc said they had received approval from U.S. regulators to start an early stage human trial testing their Zika vaccine. The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700.   “We plan to […]

Read More »

GlaxoSmithKline says lung drug meets late-stage study goals

The GlaxoSmithKline building is pictured in Hounslow, west London, Britain, June 18, 2013. Reuters/Luke MacGregor/File Photo Drugmaker GlaxoSmithKline Plc said its experimental combination therapy for a chronic lung problem met the main goal of a late-stage study, allowing the company to apply for marketing of the drug by the end of 2016. The company said […]

Read More »

Australian watchdog files suit against e-cigarette retailers

Australia’s consumer watchdog has launched a lawsuit in the Federal Court against two e-cigarette retailers, saying the companies misled consumers with claims that their products are not carcinogenic. The Australian Competition and Consumer Commission said in a statement that Australia’s Social-Lites Pty Limited and Elusion New Zealand Limited, both online retailers, claimed on their websites […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom